Validation and Exploratory Refinement of the HFA-ICOS Score for Cardiovascular Risk in Proteasome Inhibitor-Treated Multiple Myeloma: Single-Center Retrospective Study
Eduardo Pons-Fuster, Alejandro Riquelme-Perez, Vyacheslav Shumbar, Celia María González-Ponce, Juan José Fernandez-Avila, Andrés Ramón-Martínez, María José Moreno-Belmonte, Valentín Cabañas-Perianes, Domingo Pascual-Figal, María Sacramento Diaz-Carrasco, Cesar Caro-Martínez · 2026
Read Validation and Exploratory Refinement of the HFA-ICOS Score for Cardiovascular Risk in Proteasome Inhibitor-Treated Multiple Myeloma: Single-Center Retrospective Study by Eduardo Pons-Fuster, Alejandro Riquelme-Perez, Vyacheslav Shumbar, Celia María González-Ponce, Juan José Fernandez-Avila, Andrés Ramón-Martínez, María José Moreno-Belmonte, Valentín Cabañas-Perianes, Domingo Pascual-Figal, María Sacramento Diaz-Carrasco, Cesar Caro-Martínez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13297542.txt.
Description
Eduardo Pons-Fuster and ten co-authors present a 2026 study testing a heart-risk score in blood cancer patients. Proteasome inhibitors, a mainstay against multiple myeloma, can damage the heart. A European score, HFA-ICOS, was built to flag patients at risk before treatment, but its fit for myeloma was unproven. The team reviewed ninety-eight patients treated at one center from 2019 to 2024.
Heart events struck about one patient in five, mostly heart failure. The original score predicted them only modestly and labeled too many patients high risk. Two factors did predict events: use of one particular drug and a raised heart-stress marker before the second treatment cycle. A revised, updated model using those factors plus a lower age cut sorted patients far better. The authors stress the revision is exploratory and needs testing in larger groups before clinical use.
Catalog record
| CREATOR | Eduardo Pons-Fuster, Alejandro Riquelme-Perez, Vyacheslav Shumbar, Celia María González-Ponce, Juan José Fernandez-Avila, Andrés Ramón-Martínez, María José Moreno-Belmonte, Valentín Cabañas-Perianes, Domingo Pascual-Figal, María Sacramento Diaz-Carrasco, Cesar Caro-Martínez |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |